AusperBio (Series B)

Funding Details
Awarder
Inbox
Date Award
December 27, 2024
Vertical
Biopharmaceuticals
Funding URL
View Funding Page
Funding Amount:
$73,000,000

Company Info
Founders
Dr. Guofeng Cheng
Company Description
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.
Market
Chronic hepatitis B infection treatment
Location
San Mateo, California, USA
Coinvestors
CDH Investments, HanKang Capital, InnoPinnacle Fund, Qiming Venture Partners, Sherpa Capital, YuanBio Venture Capital

Links